Severe progression of glaucomatous optic neuropathy in patients with Alzheimer’s disease
✍ Scribed by Bayer, A U; Ferrari, F
- Book ID
- 110034752
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 79 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0950-222X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective: To examine the reliability and the validity of the korean version of the sib (sib-k); and to determine its usefulness in patients with severe dementia. ## Methods: Sixty-five patients (56 women, nine men) who lived in a nursing home and met the criteria of the diagnostic and statist
## Abstract ## Background Cholinesterase (ChE) inhibitors are primarily used in the treatment of mild to moderate Alzheimer's disease (AD), but may also be effective in more severe disease. ## Objective To evaluate the dual ChE inhibitor, rivastigmine, in more severe dementia. ## Methods We re